Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nina Parthasarathy"'
Autor:
Tony Long, Anna Wan, Declan Connoley, Maria Bishara, Danny Con, Peter R. Gibson, Abhinav Vasudevan, James A Rickard, Neetima Joshi, Daniel R. van Langenberg, Nina Parthasarathy, Raphael P. Luber, Miles P. Sparrow
Publikováno v:
Journal of Crohn's and Colitis. 15:583-593
Background Early or first-line treatment with biologics, as opposed to conventional immunomodulators, is not always necessary to achieve remission in Crohn’s disease [CD] and may not be cost-effective. This study aimed to develop a simple model to
Autor:
Alex Barnes, Soong-Yuan J. Ooi, Kate D. Lynch, Nina Parthasarathy, Maria Bishara, Michael Gounder, Rachel Grafton, Peta Leach, Peter Bampton, Alexandra Sechi, Watson Ng, Susan Connor, Daniel van Langenberg, Réme Mountifield, Jane M. Andrews
Publikováno v:
Digestive diseases and sciences.
The thiopurine medications are well established in the treatment of inflammatory bowel disease (IBD). There is significant variation in levels of toxic and therapeutic metabolites. Current data from small or short-term studies support therapeutic dru
Autor:
Daniel R. van Langenberg, Anna Wan, James A Rickard, Tony Long, Peter R. Gibson, Steven Nicolaides, Maria Bishara, Miles P. Sparrow, Abhinav Vasudevan, Ross Apostolov, Declan Connoley, Danny Con, Nina Parthasarathy, Raphael P. Luber, Ayushi Chauhan, Neetima Joshi
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 52(7)
Background There are safety concerns regarding immunomodulators (thiopurines and methotrexate) for treatment of inflammatory bowel disease (IBD). Aim To compare the long-term tolerability, and persistence of thiopurine and methotrexate therapy in IBD
Autor:
Nina Parthasarathy, John S Lubel, Amanda Nicoll, Abhinav Vasudevan, Desmond Patrick, Sern Wei Yeoh
Publikováno v:
Gastroenterology. 150:S1126